Marshall Wace LLP Has $597,000 Stock Position in Oscar Health, Inc. (NYSE:OSCR)

Marshall Wace LLP cut its holdings in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 87.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 44,400 shares of the company's stock after selling 298,338 shares during the quarter. Marshall Wace LLP's holdings in Oscar Health were worth $597,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the stock. JPMorgan Chase & Co. increased its position in Oscar Health by 348.7% during the 4th quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company's stock worth $139,246,000 after purchasing an additional 8,051,379 shares in the last quarter. BIT Capital GmbH lifted its holdings in shares of Oscar Health by 5,711.6% during the 4th quarter. BIT Capital GmbH now owns 4,473,853 shares of the company's stock valued at $60,129,000 after acquiring an additional 4,396,872 shares in the last quarter. Hennessy Advisors Inc. boosted its position in shares of Oscar Health by 550.3% in the fourth quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company's stock worth $56,292,000 after buying an additional 3,544,300 shares during the period. Clearbridge Investments LLC purchased a new stake in shares of Oscar Health during the fourth quarter valued at approximately $19,088,000. Finally, American Century Companies Inc. increased its stake in Oscar Health by 185.6% during the 4th quarter. American Century Companies Inc. now owns 1,285,204 shares of the company's stock worth $17,273,000 after buying an additional 835,144 shares during the period. Hedge funds and other institutional investors own 75.70% of the company's stock.

Oscar Health Stock Performance

OSCR traded down $0.22 during trading on Monday, reaching $12.99. 4,558,581 shares of the company's stock were exchanged, compared to its average volume of 3,926,081. Oscar Health, Inc. has a fifty-two week low of $11.20 and a fifty-two week high of $23.79. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The company has a market capitalization of $3.25 billion, a P/E ratio of -648.93 and a beta of 1.75. The business has a 50 day moving average price of $13.25 and a 200 day moving average price of $14.62.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. As a group, analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Wells Fargo & Company lowered Oscar Health from an "overweight" rating to an "equal weight" rating and decreased their target price for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating, two have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Oscar Health presently has an average rating of "Hold" and a consensus price target of $20.21.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.